RYAM stock holds steady on Rayonier Advanced Materials results

Rayonier Advanced Materials (ISIN US75522E1082) remains centered on its latest reported operating numbers, including 2025 revenue, adjusted EBITDA, and year-end debt. Those figures frame RYAM stock after the company’s most recent disclosure and give investors a dated baseline for the shares.

2025 revenue and EBITDA

Rayonier Advanced Materials reported 2025 revenue of $1.4 billion, adjusted EBITDA of $152 million, and net debt of $615 million in its latest annual materials. The company also cited 2025 total sales volume of 1.6 million metric tons, which provides the operating scale behind the year-end income statement.

That combination matters because adjusted EBITDA of $152 million on $1.4 billion of revenue implies a margin that is still sensitive to volume mix and pricing. The debt figure of $615 million also keeps balance-sheet leverage part of the valuation discussion.

Margin and leverage

The most useful comparison in the current setup is the gap between revenue and earnings power: $1.4 billion in 2025 revenue against $152 million in adjusted EBITDA leaves limited room for a sharp margin swing. RYAM stock therefore tracks execution on pricing, cost control, and mill utilization more than broad market themes.

The company also highlighted 1.6 million metric tons of 2025 sales volume, which shows that the operating base remains sizeable even when profitability is thinner than revenue scale alone would suggest. For the market, that makes the debt-to-earnings relationship a central watch point.

Specialty cellulose

The company’s relevant product base is specialty cellulose, the industrial line that underpins most of Rayonier Advanced Materials’ earnings profile. In 2025, that platform supported the reported revenue, EBITDA, and volume totals, so product mix remains central to any reassessment of RYAM stock.

A product line like specialty cellulose matters because margin recovery usually depends on the spread between higher-value grades and the company’s input and conversion costs. That is why the 2025 EBITDA figure is more informative than revenue alone.

Shares and valuation

RYAM stock is best read against the company’s 2025 operating baseline rather than against broad market language. The latest disclosed numbers - $1.4 billion revenue, $152 million adjusted EBITDA, and $615 million net debt - define the financial backdrop as of fiscal 2025.

Rayonier Advanced Materials is traded on the New York Stock Exchange under the ticker NYSE: RYAM, with the 2025 report providing the clearest numerical reference point for the share. The same figures also show why debt and margin remain more important than raw top-line size.